IL2 and Huntington disease: In contrast, a second group (CD46I, approximately 30%; 14/49 HD and 18/58 AEA patients) show an increase in CD46 expression after stimulation with αCD3/αCD46/IL-2 and calcitriol when compared with stimulation αCD3/αCD46/IL-2 alone.